This Startup Can Improve Cancer Screenings, Starting With Mammograms

As of March 2023, the Food and Drug Administration required that mammogram facilities start notifying patients about their breast density so that they know their risks and can act accordingly, such as pursuing another imaging option. As Marissa Fayer MBA, CEO of Deeplook Medical, adds, a post-mammogram note about breast density puts the onus around patients to decide their next steps and balance risks and costs. Deeplook Medical, in contrast, can give information beyond just breast density to help empower and inform both patients and healthcare providers. Read more >>